LENTIPAK
Dead / Cancelled — Cancelled — Section 8 (as of 21 Jun 2013)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78141231
- Registration number
- 3171963
- Mark type
- Word mark
- Filed
- 03 Jul 2002
- Published for opposition
- 09 Sept 2003
- Registered
- 14 Nov 2006
- Attorney of record
- Michael J. Bevilacqua, Esquire
Goods and services
- Class 005 — Pharmaceuticals: bioengineered component for a therapeutic material, namely, lentiviral vectors and packaging cell lines used for gene therapy
Owner
- BLUEBIRD BIO, INC., CAMBRIDGE, MA, US
- Genetix Pharmaceuticals, Inc., Cambridge, MA, US
- Genetix Pharmaceuticals, Inc., Cambridge, MA, US
- Genetix Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 21 Jun 2013 — CANCELLED SEC. 8 (6-YR)
- 28 Nov 2012 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Nov 2006 — REGISTERED-PRINCIPAL REGISTER
- 01 Nov 2006 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 04 Oct 2006 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 03 Oct 2006 — ASSIGNED TO LIE
- 28 Sept 2006 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Aug 2006 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jul 2006 — USE AMENDMENT FILED
- 14 Jul 2006 — TEAS STATEMENT OF USE RECEIVED
- 25 May 2006 — SOU EXTENSION 5 GRANTED
- 25 May 2006 — SOU EXTENSION 5 FILED
- 25 May 2006 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2005 — SOU EXTENSION 4 GRANTED
- 02 Dec 2005 — SOU EXTENSION 4 FILED